A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Understand the impact of robotic-assisted prostate cancer surgery and real-time analysis on surgical precision and patient ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

Prostate cancer diagnoses have reached a record high after campaigns urging men to come forward for checks. Official data ...

According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...

This story is sponsored by Revere Health. Holmium Laser Enucleation of the Prostate (HoLEP) is rapidly becoming the gold standard surgical treatment for benign prostatic hyperplasia (BPH), and there ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...

Prostate cancer screening could prevent around 1,500 deaths a year in the UK, research suggests. A European trial, one of the ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...